(1)
Release
of confidential information. Confidential information may be released
only as follows:
a. Pursuant to the express
written authorization of the patient or the order or direction of a
court.
b. To the patient or the
patient's authorized representative.
c. To the prescriber or other licensed
practitioner then caring for the patient.
d. To another licensed pharmacist when the
best interests of the patient require such release.
e. To the board or its representative or to
such other persons or governmental agencies duly authorized by law to receive
such information.
A pharmacist shall utilize the resources available to
determine, in the professional judgment of the pharmacist, that any persons
requesting confidential patient information pursuant to this rule are entitled
to receive that information.
(2)
Exceptions. Nothing in
this rule shall prohibit a pharmacist from releasing confidential patient
information as follows:
a. Transferring a
prescription to another pharmacy upon the request of the patient or the
patient's authorized representative or pursuant to subrule 8.35(7) when the
pharmacy is discontinuing operations.
b. Providing the patient with a copy of a
nonrefillable prescription that is clearly marked as a copy and not to be
filled.
c. Providing drug therapy
information to authorized practitioners for their patients.
d. Disclosing information necessary for the
processing of third-party payer claims on behalf of the patient.
(3)
Record
disposal. Disposal of any materials containing or including
patient-specific or confidential information shall be conducted in a manner to
preserve patient confidentiality.
Notes
Iowa Admin. Code
r. 657-8.16
ARC 9526B, IAB
6/1/11, effective 7/6/11; ARC
3858C, IAB 6/20/18, effective 7/25/18
ARC 9526B, IAB 6/1/11,
effective 7/6/11
Amended by
IAB
June 20, 2018/Volume XL, Number 26, effective
7/25/2018
Rescinded by
IAB
June 11, 2025/Volume XLVII, Number 25, effective
7/16/2025